Katsikis P D, Pavlidis N A, Papadopoulos N M, Bai M, Moutsopoulos H M
Laboratory of Clinical Immunology, School of Medicine, University of Ioannina, Greece.
Anticancer Res. 1990 Nov-Dec;10(6):1719-24.
The presence of serum monoclonal or oligoclonal immunoglobulins (paraproteins) was investigated in 38 non-Hodgkin's lymphoma and chronic lymphocytic leukemia patients, 33 patients with solid tumors and 33 healthy individuals. Seventy two percent of non-Hodgkin's lymphoma and 31% of chronic lymphocytic leukemia patients had serum paraproteins, in contrast to 21% and 15% of solid tumor patients and normal controls respectively. There was no significant prevalence of a certain isotype or light chain in the non-Hodgkin's lymphoma, chronic lymphocytic leukemia and solid tumor groups. In the healthy individuals all bands were monoclonal of the IgG isotype. No correlation was found between histologic grading of lymphoid malignancy or disease stage and serum monoclonality. No serologic or histologic autoimmune features were demonstrated in non-Hodgkin's lymphoma and chronic lymphocytic leukemia patients. In addition, no correlation was found between serum autoantibody activity and mono- or oligoclonal immunoglobulins.
在38例非霍奇金淋巴瘤和慢性淋巴细胞白血病患者、33例实体瘤患者以及33名健康个体中,对血清单克隆或寡克隆免疫球蛋白(副蛋白)的存在情况进行了研究。非霍奇金淋巴瘤患者中有72%以及慢性淋巴细胞白血病患者中有31%存在血清副蛋白,相比之下,实体瘤患者和正常对照者的这一比例分别为21%和15%。在非霍奇金淋巴瘤、慢性淋巴细胞白血病和实体瘤组中,特定同种型或轻链并无显著的流行情况。在健康个体中,所有条带均为IgG同种型的单克隆条带。未发现淋巴恶性肿瘤的组织学分级或疾病分期与血清单克隆性之间存在相关性。在非霍奇金淋巴瘤和慢性淋巴细胞白血病患者中未表现出任何血清学或组织学自身免疫特征。此外,未发现血清自身抗体活性与单克隆或寡克隆免疫球蛋白之间存在相关性。